UnitedHealth Group Inc (UNH) Upgraded to Buy by BidAskClub

UnitedHealth Group Inc (NYSE:UNH) was upgraded by stock analysts at BidAskClub from a “hold” rating to a “buy” rating in a research note issued on Friday.

Other research analysts also recently issued reports about the company. Vetr downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 10th. Deutsche Bank AG assumed coverage on UnitedHealth Group in a research note on Wednesday, April 5th. They set a “buy” rating and a $183.00 target price on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $205.00 target price (up from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, May 29th. Finally, Jefferies Group LLC restated a “buy” rating and set a $192.00 target price (up from $186.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Two research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $184.23.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) traded up 0.32% during midday trading on Friday, hitting $182.27. The stock had a trading volume of 271,816 shares. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $183.76. The company’s 50 day moving average price is $174.80 and its 200-day moving average price is $165.82. The stock has a market cap of $175.65 billion, a PE ratio of 23.33 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm had revenue of $48.72 billion for the quarter, compared to the consensus estimate of $48.21 billion. During the same period in the previous year, the business earned $1.81 EPS. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. Analysts forecast that UnitedHealth Group will post $9.80 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be given a $0.75 dividend. The ex-dividend date is Thursday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.63. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.65%. UnitedHealth Group’s dividend payout ratio is 33.47%.

WARNING: “UnitedHealth Group Inc (UNH) Upgraded to Buy by BidAskClub” was posted by Mideast Time and is the sole property of of Mideast Time. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://www.mideasttime.com/unitedhealth-group-inc-unh-upgraded-to-buy-by-bidaskclub/1766154.html.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, April 20th. The stock was sold at an average price of $170.47, for a total value of $852,350.00. Following the completion of the transaction, the director now directly owns 75,735 shares in the company, valued at $12,910,545.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michele J. Hooper sold 15,000 shares of the stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $170.89, for a total value of $2,563,350.00. Following the completion of the transaction, the director now owns 35,941 shares of the company’s stock, valued at $6,141,957.49. The disclosure for this sale can be found here. Insiders sold 45,378 shares of company stock valued at $7,848,402 over the last 90 days. Company insiders own 1.65% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. raised its position in shares of UnitedHealth Group by 2,188.4% in the first quarter. BlackRock Inc. now owns 68,633,762 shares of the healthcare conglomerate’s stock valued at $11,256,624,000 after buying an additional 65,634,528 shares during the last quarter. Dodge & Cox purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. TPG Group Holdings SBS Advisors Inc. purchased a new position in UnitedHealth Group during the first quarter worth approximately $510,530,000. Finally, Vanguard Group Inc. boosted its position in UnitedHealth Group by 4.6% in the first quarter. Vanguard Group Inc. now owns 62,990,102 shares of the healthcare conglomerate’s stock worth $10,331,007,000 after buying an additional 2,778,336 shares during the period. Institutional investors own 86.67% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “UNH”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.